Agenus Inc (AGEN) Q2 2020 Earnings Call Transcript
AGEN earnings call for the period ending June 30, 2020.
Agenus
AGEN
AGEN
$3.75
$0.44
13.3%
Price as of August 7, 2020, 4:30 p.m. EDT
View Interactive AGEN Charts
A biotechnology company, developing technologies and products to treat cancers and infectious diseases, based on immunological approaches.
Interactive Chart
News & Analysis: Agenus
The Fool has written over 100 articles on Agenus.
Here's Why Agenus Stock Jumped Higher Today
The development-stage biopharma delivered two encouraging updates.
Why Agenus Stock Took Flight in May
The immunotherapy company may be a diamond in the rough.
Here's Why Agenus Rose as Much as 23.3% Today
The biopharma company provided a clinical update for an important pipeline asset.
Agenus Inc (AGEN) Q1 2020 Earnings Call Transcript
AGEN earnings call for the period ending March 31, 2020.
3 Top Stocks Under $5 to Buy Now
Agenus, Dynavax Technologies, and Verastem Oncology could all be outstanding picks for risk-tolerant investors.
Top Pharma Stocks Under $5
These clinical-stage drugmakers could be a steal at current levels.
Agenus Inc (AGEN) Q4 2019 Earnings Call Transcript
AGEN earnings call for the period ending December 31, 2019.
Here's Why Agenus Tumbled Today
Results from an experimental combination therapy were impressive, but they might not be impressive enough.
Agenus Stock Rises Ahead of Investor Day Presentation
The biopharma is scheduled to update investors and Wall Street analysts on two important pipeline programs on Feb. 20.
